DENIS CHEM LAB
|
DENIS CHEM LAB Last 5 Year Financial Ratios History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 5.66 | 4.51 | 1.63 | 3.04 | 4.58 |
CEPS(Rs) | 11.30 | 8.66 | 5.93 | 7.84 | 9.16 |
DPS(Rs) | 2.00 | 1.50 | 0.75 | - | 1.00 |
Book NAV/Share(Rs) | 52.08 | 47.89 | 44.32 | 42.58 | 40.69 |
Tax Rate(%) | 28.00 | 29.50 | 26.65 | 26.41 | -7.23 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 11.68 | 10.51 | 9.38 | 11.02 | 11.18 |
EBIT Margin(%) | 7.19 | 7.06 | 4.25 | 6.33 | 7.39 |
Pre Tax Margin(%) | 6.79 | 6.51 | 2.82 | 4.21 | 4.77 |
PAT Margin (%) | 4.89 | 4.59 | 2.07 | 3.10 | 5.12 |
Cash Profit Margin (%) | 9.75 | 8.80 | 7.52 | 7.99 | 10.24 |
Performance Ratios | |||||
ROA(%) | 8.03 | 6.64 | 2.39 | 4.15 | 6.15 |
ROE(%) | 11.33 | 9.79 | 3.76 | 7.29 | 11.94 |
ROCE(%) | 16.07 | 13.79 | 6.50 | 11.34 | 11.90 |
Asset Turnover(x) | 1.64 | 1.45 | 1.15 | 1.34 | 1.20 |
Sales/Fixed Asset(x) | 1.59 | 1.39 | 1.16 | 1.47 | 1.49 |
Working Capital/Sales(x) | 4.57 | 4.88 | 4.66 | 8.69 | 11.00 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.63 | 0.72 | 0.87 | 0.68 | 0.67 |
Receivable days | 71.57 | 86.49 | 113.29 | 95.09 | 98.13 |
Inventory Days | 21.57 | 25.39 | 29.45 | 22.73 | 22.84 |
Payable days | 82.06 | 89.23 | 111.66 | 104.74 | 111.42 |
Valuation Parameters | |||||
PER(x) | 11.26 | 15.10 | 22.89 | 9.76 | 16.89 |
PCE(x) | 5.65 | 7.87 | 6.30 | 3.78 | 8.44 |
Price/Book(x) | 1.22 | 1.42 | 0.84 | 0.70 | 1.90 |
Yield(%) | 3.14 | 2.20 | 2.01 | - | 1.29 |
EV/Net Sales(x) | 0.46 | 0.65 | 0.51 | 0.37 | 1.00 |
EV/Core EBITDA(x) | 3.79 | 5.78 | 5.27 | 3.34 | 8.01 |
EV/EBIT(x) | 6.36 | 9.23 | 12.05 | 5.92 | 13.57 |
EV/CE(x) | 0.74 | 0.92 | 0.61 | 0.52 | 1.18 |
M Cap / Sales | 0.55 | 0.69 | 0.47 | 0.30 | 0.86 |
Growth Ratio | |||||
Net Sales Growth(%) | 17.79 | 24.92 | -19.71 | 9.68 | 15.78 |
Core EBITDA Growth(%) | 25.82 | 45.27 | -30.65 | -1.60 | 23.44 |
EBIT Growth(%) | 19.89 | 107.72 | -46.15 | -6.06 | 37.89 |
PAT Growth(%) | 25.50 | 176.59 | -46.26 | -33.63 | 196.19 |
EPS Growth(%) | 25.50 | 176.59 | -46.27 | -33.63 | 196.19 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.03 | 0.05 | 0.14 | 0.23 | 0.40 |
Current Ratio(x) | 2.46 | 2.11 | 1.93 | 1.46 | 1.26 |
Quick Ratio(x) | 2.08 | 1.72 | 1.57 | 1.21 | 1.07 |
Interest Cover(x) | 18.02 | 12.74 | 2.99 | 2.98 | 2.82 |
Total Debt/Mcap(x) | 0.02 | 0.03 | 0.17 | 0.33 | 0.21 |
Compare Financial Ratios of peers of DENIS CHEM LAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DENIS CHEM LAB | ₹278.1 Cr | -7.8% | 21.8% | 159.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹370,757.0 Cr | 0.7% | -4.8% | 57.3% | Stock Analytics | |
CIPLA | ₹109,559.0 Cr | 1.9% | -2.4% | 42.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,416.0 Cr | 0.1% | 3% | 12.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,088.9 Cr | 1.3% | 0.5% | 87.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,939.0 Cr | -5.4% | -4.1% | 20% | Stock Analytics |
DENIS CHEM LAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DENIS CHEM LAB | -7.8% |
21.8% |
159.1% |
SENSEX | -0.6% |
-2.1% |
18.4% |
You may also like the below Video Courses